ChemicalBook > Product Catalog >API >Anesthetic Agents >General anesthetics >KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO

KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO

KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Basic information
Product Name:KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO
Synonyms:2-(2-chlorophenyl)-2-methylaminocyclohexanone;Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-;(±)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone;Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI);dl-Ketamine;Ketoject;NSC 70151;C07525
CAS:6740-88-1
MF:C13H16ClNO
MW:237.73
EINECS:229-804-1
Product Categories:
Mol File:6740-88-1.mol
KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Structure
KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Chemical Properties
Melting point 92-93°
Boiling point 363.8±42.0 °C(Predicted)
density 1.0982 (rough estimate)
refractive index 1.6330 (estimate)
pka7.5(at 25℃)
EPA Substance Registry SystemCyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (6740-88-1)
Safety Information
RIDADR 3249
HazardClass 6.1(b)
PackingGroup III
Hazardous Substances Data6740-88-1(Hazardous Substances Data)
MSDS Information
KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Usage And Synthesis
OriginatorKetanest,Parke Davis,W. Germany,1969
UsesAnesthetic.
DefinitionChEBI: Ketamine is a member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. It has a role as an intravenous anaesthetic, a NMDA receptor antagonist, an analgesic, a neurotoxin, an environmental contaminant and a xenobiotic. It is a member of cyclohexanones, a secondary amino compound and a member of monochlorobenzenes.
Manufacturing ProcessThe 1-hydroxycyclopentyl-(o-chlorophenyl)-ketone N-methylimine used as an intermediate is prepared as follows. To the Grignard reagent prepared from 119.0 g of cyclopentyl bromide and 19.4 g of magnesium is added 55.2 g of o-chlorobenzonitrile. The reaction mixture is stirred for 3 days and thereafter hydrolyzed in the usual manner. From the hydrolysis there is obtained ochlorophenylcyclopentylketone, BP 96° to 97°C (0.3 mm), nD251.5452. To 21.0 g of the ketone is added 10.0 g of bromine in 80 ml of carbon tetrachloride.
1-Bromocyclopentyl-(o-chlorophenyl)-ketone, BP 111° to 114°C (0.1 mm) is isolated in the usual manner. Since it is unstable, it must be used immediately. The bromoketone (29.0 g) is dissolved in 50 ml of liquid methylamine. After one hour, the excess liquid methylamine is allowed to evaporate. The organic residue is dissolved in pentane, and upon evaporation of the solvent, 1-hydroxycyclopentyl-(o-chlorophenyl)-ketone N-methylimine, MP 62°C, is isolated.
1-Hydroxycyclopentyl-(o-chlorophenyl)-ketone N-methylimine (2.0 g) is dissolved in 15 ml of Decalin and refluxed for 2,5 hours. After evaporation of the Decalin under reduced pressure, the residue is extracted with dilute hydrochloric acid, the solution treated with decolorizing charcoal, and the resulting acidic solution is made basic. The liberated product, 2-methylamino- 2-(o-chlorophenyl)-cyclohexanone, after crystallization from pentane-ether, has MP 92° to 93°C. The hydrochloride of this compound has MP 262° to 263°C.
Brand nameKetalar (Parkdale).
Therapeutic FunctionAnesthetic
Mechanism of actionThe mode of action of ketamine differs from that of the barbiturates. It suppresses the activities of the cerebral cortex (consciousness) and the thalamic pain pathways (analgesia). Parts of the upper brainstem and the limbic system are not affected (so-called dissociative analgesia). The patient exhibits a characteristic superficial sleep with complete elimination of pain. Because of the psychomotor side effects, combination with neuroleptics and tranquilizers is necessary. Ketamine is used especially in pediatrics. The usual preparations are 0.1 % and 0.5 % solutions.
Clinical UseKetamine is a short-acting anesthetic effective for 5 – 30 min, depending on the amount injected. It is suitable for diagnostic purposes and for surgical procedures that do not require muscle relaxation. The occasional hallucinations that occur during anesthesia suggest a chemical relationship to phencyclidine, which was used as a short-acting anesthetic until identified as a dangerous drug of abuse.
SynthesisIt is prepared by bromination of o-chlorophenyl cyclopentyl ketone, which is then reacted with methylamine to give the methylimino alcohol. Thermolysis of the imino hydrochloride yields ketamine by ring expansion :
Synthesis_6740-88-1
KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Preparation Products And Raw materials
Raw materialsMethylamine-->Magnesium-->Bromocyclopentane-->2-Chlorobenzonitrile
Preparation Products(S)-(+)-Ketamine hydrochloride
Tag:KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO(6740-88-1) Related Product Information
Ketamine hydrochloride